- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07415798
A Quantitative, Cross-Sectional and Observational Study to Characterize Age-Related Structural Changes in Facial Skin of Chinese Women Using Line-Field Confocal Optical Coherence Tomography (LC-OCT)
February 10, 2026 updated by: ChinaNorm
This is a single-center, non-interventional, observational, cross-sectional clinical study designed to quantitatively and qualitatively characterize skin properties in a cohort of 100 Chinese female Subjects aged 20 to 70 years.
The study involves no product application and poses minimal risk to participants.
The primary objectives are to establish a comprehensive skin aging profile database, characterize skin color, aging signs, and biomechanical properties, and create a histomorphometric database for the development and validation of ordinal photographic scales for aging research.
Data will be collected through questionnaires, clinical assessments (including LC-OCT imaging), standardized photography, and non-invasive biophysical measurements.
All procedures will be conducted in accordance with the ethical principles originating from the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and the relevant laws and regulations of China (including the *Measures for the Ethical Review of Biomedical Research Involving Human Subjects*).
All data will be anonymized and stored securely.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yanwen Jiang
- Phone Number: 13501700841
- Email: jiangyanwen@china-norm.com
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200072
- Recruiting
- HKRI Centre One
-
Contact:
- Yanwen Jiang
- Phone Number: 13501700841
- Email: jiangyanwen@china-norm.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Approximately 100 healthy Chinese female Subjects, evenly distributed across age groups (20-29, 30-39, 40-49, 50-59, 60-70 years).
Description
Inclusion Criteria:
- Chinese female, aged between 20 and 70 years (inclusive) at the time of signing consent.
- Willing and able to provide written informed consent.
- Fitzpatrick Skin Phototype II or III.
- Willing to comply with all study procedures, including removal of facial makeup and avoidance of intensive skincare (e.g., retinoids, strong acids) on the test areas for 3 days prior to the visit as per instructions.
Exclusion Criteria:
- Pregnant, planning pregnancy, or breastfeeding (as hormonal changes significantly affect skin properties).
- Presence of temporary tanning, sunburn, or significant erythema on the face or measurement areas.
- Presence of facial piercings, tattoos, too much fluff or significant scarring that would interfere with imaging or measurements in the areas of interest.
- History of any aesthetic or surgical procedure on the face (e.g., laser therapy, chemical peels, injectable fillers, botulinum toxin, plastic surgery) within the past 12 months.
- Current diagnosis or visible signs of a skin disease (e.g., psoriasis, eczema, active acne, rosacea) or a systemic disease known to affect the skin (e.g., diabetes, lupus) on the face or measurement areas.
- Use of systemic medications known to affect skin physiology (e.g., oral retinoids, immunosuppressants, long-term corticosteroids) within the past 3 months, or for a cumulative duration of ≥6 months within the past 2 years.
- Participation in another clinical study on the face or arms within the past 1 month.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 20 to 29 Years old
|
|
Group 30 to 39 Years old
|
|
Group 40 to 49 Years old
|
|
Group 50 to 59 Years old
|
|
Group 60 to 69 Years old
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Epidermal Thickness
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Dermal-Epidermal Junction (DEJ) Undulation Index
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Mean Dermal Reflectivity
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Stratum Corneum Thickness
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Correlation between LC-OCT parameters and chronological age
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Skin colorimetric parameter L*a*b*
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Correlation between LC-OCT parameters and clinician-graded scores
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Correlation between LC-OCT parameters and questionnaire factors
Time Frame: Single visit, day 1
|
Single visit, day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Clinician-graded score of skin texture/pores
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Clinician-graded score of skin pigmentation
Time Frame: Single visit, day 1
|
Single visit, day 1
|
|
Clinician-graded score of facial wrinkles
Time Frame: Single visit, day 1
|
Single visit, day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 15, 2027
Study Registration Dates
First Submitted
February 10, 2026
First Submitted That Met QC Criteria
February 10, 2026
First Posted (Actual)
February 17, 2026
Study Record Updates
Last Update Posted (Actual)
February 17, 2026
Last Update Submitted That Met QC Criteria
February 10, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- CN25038-CLI-SC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female
-
Zagazig UniversityNot yet recruitingHemodynamic Instability | Infertility FemaleEgypt
-
Assiut UniversityNot yet recruitingFemale InfertilityEgypt
-
University of Novi SadNot yet recruitingInfertility Female | Frozen Embryo Transfer (FET)Serbia
-
Nadezhda Women's Health HospitalRecruitingFemale Infertility | IVF PatientsBulgaria
-
American Hospital 2 KosovoNot yet recruitingInfertility, FemaleKosovo
-
West China Second University HospitalJiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Clinique MathildeCompleted
-
Region StockholmKarolinska InstitutetNot yet recruiting
-
Beni-Suef UniversityRecruitingInfertility, Female | IVFEgypt
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)